Iran, Islamic Republic of vs Japan: Share of S. aureus infections resistant to methicillin
Iran, Islamic Republic of
34.7%
in 2022
Japan
33.9%
in 2022
Iran, Islamic Republic of rank
17th
Japan rank
18th
Share of S. aureus infections resistant to methicillin over time
- Iran, Islamic Republic of
- Japan
How they compare
Iran, Islamic Republic of currently reports 34.7% against 33.9% in Japan, a difference of 0.8%.
The two have swapped places 3 times across 5 shared years of data; in 2018 it was Japan ahead.
Iran, Islamic Republic of ranks 17th and Japan ranks 18th of 45 countries.
Iran, Islamic Republic of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iran, Islamic Republic of | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 38.8% | 38.5% | 0.3% | Iran, Islamic Republic of |
| 2020s | 37.2% | 34.9% | 2.3% | Iran, Islamic Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Iran, Islamic Republic of or Japan?
- Iran, Islamic Republic of, at 34.7% against 33.9% in Japan as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Iran, Islamic Republic of and Japan?
- 0.8%, with Iran, Islamic Republic of ahead.
- How many years of comparable data are there for Iran, Islamic Republic of and Japan?
- 5 years are reported by both, from 2018 to 2022.
- How do Iran, Islamic Republic of and Japan rank globally for share of s. aureus infections resistant to methicillin?
- Iran, Islamic Republic of ranks 17th and Japan ranks 18th of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).